share_log

HC Wainwright & Co. Reiterates Neutral on CytomX Therapeutics

Benzinga ·  May 9 10:08

HC Wainwright & Co. analyst Mitchell Kapoor reiterates CytomX Therapeutics (NASDAQ:CTMX) with a Neutral.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment